Servier to acquire Danish antibody discovery company Symphogen
Servier acquisition of Symphogen : French pharma company Servier has agreed to acquire Danish antibody discovery company Symphogen, for an undisclosed price to boost its antibody capabilities while ensuring that its own antibody discovery and early-development platform is fully leveraged. As part of the deal, Servier will get access to Symphogen’s oncology and immune-oncology pipeline […]